The Medical Letter - 2021
Search or Select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Year:    Publication:     
November 29, 2021 (Issue 1638)  
November 15, 2021 (Issue 1637)  
November 1, 2021 (Issue 1636)  
October 18, 2021 (Issue 1635)  
October 4, 2021 (Issue 1634)  
September 20, 2021 (Issue 1633)  
September 6, 2021 (Issue 1632)  
August 23, 2021 (Issue 1631)  
August 9, 2021 (Issue 1630)  
July 26, 2021 (Issue 1629)  
July 12, 2021 (Issue 1628)  
  • Aducanumab (Aduhelm) for Alzheimer's Disease   
    Aducanumab-avwa (Aduhelm – Biogen/Eisai), an IV amyloid beta-directed monoclonal antibody, has received accelerated approval from the FDA for treatment of Alzheimer's disease. The...
  • Semaglutide (Wegovy) for Weight Loss   
    The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide, previously approved by the FDA as Ozempic to treat type 2 diabetes and to reduce the risk of major adverse...
  • Insect Repellents   
    The Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) recommend using insect repellents to prevent infections transmitted by mosquitoes and...
June 28, 2021 (Issue 1627)  
June 14, 2021 (Issue 1626)  
  • Drugs for Chronic Heart Failure   
    Among patients with chronic heart failure, those with a left ventricular ejection fraction (LVEF) ≤40% are considered to have heart failure with reduced ejection fraction (HFrEF). Patients...
May 31, 2021 (Issue 1625)  
May 17, 2021 (Issue 1624)  
May 3, 2021 (Issue 1623)  
April 19, 2021 (Issue 1622)  
April 5, 2021 (Issue 1621)  
March 22, 2021 (Issue 1620)  
March 8, 2021 (Issue 1619)  
February 22, 2021 (Issue 1618)  
February 8, 2021 (Issue 1617)  
January 25, 2021 (Issue 1616)  
January 11, 2021 (Issue 1615)